Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.86 +0.01 (+0.11%)
As of: Oct 22, 2026 · 3:48 PM EDT

Aspire Biopharma Holdings, Inc. (ASBP) Return on Assets [ROA] (2025 - 2026)

Updated

Aspire Biopharma Holdings (ASBP) recorded Return on Assets [ROA] of -147.15% in Q2 2026, up 1125.74 percentage points from -1272.89% a year earlier and up 230.40 percentage points from the prior quarter.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) Return on Assets [ROA] (2025 - 2026) Analysis & Trends

For FY2025, Aspire Biopharma Holdings reported Return on Assets [ROA] of -3353.18%, down 3340.17 percentage points from FY2024.

  • Across earlier years, Return on Assets [ROA] came in at -13.01% in FY2024 (-12.79 pp) and -0.22% in FY2023.
  • Per Business Quant, the preceding three quarters came in at -377.55% (Q1 2026), -1541.25% (Q4 2025) and -1250.73% (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -147.15%
Mar 31, 2026 -377.55%
Dec 31, 2025 -1,541.25%
Sep 30, 2025 -1,250.73%
Jun 30, 2025 -1,272.89%
API Access

Aspire Biopharma Holdings, Inc. Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ASBP&period=max&api_key=YOUR_API_KEY